Valuation: genedrive plc

Market Cap 20.87M 28.46M 24.39M 22.85M 39.39M 2.71B 39.78M 270M 105M 1.37B 107M 105M 4.53B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.85M 23.01M 21.56M 37.16M 2.56B 37.53M 254M 98.98M 1.29B 101M 98.61M 4.28B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.5%
Yield 2024 *
-
Yield 2025 -
1 day+3.81%
1 week+7.96%
Current month+34.95%
1 month+28.52%
3 months+12.46%
6 months+30.39%
Current year+54.23%
1 week 1.24
Extreme 1.245
1.4
1 month 0.95
Extreme 0.95
1.4
Current year 0.75
Extreme 0.75
1.5
1 year 0.19
Extreme 0.19
1.5
3 years 0.19
Extreme 0.19
14.8
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 06/08/2024
Director of Finance/CFO 48 07/04/2022
Director TitleAgeSince
Director/Board Member 69 09/04/2018
Director/Board Member 52 22/08/2018
Director/Board Member 56 11/09/2023
Date Insider Type Main position Quantity % Market Cap.
20/12/24 Buy

Chief Financial Officer

1,000,000 0.1841%
20/12/24 Free 400,000 0.0736%
20/12/24 Buy

Chief Executive Officer

1,135,208 0.2090%
Change 5-day change 1-year change 3-year change Capi.($)
+3.81%+7.96%+74.13%-88.98% 28.46M
-0.41%+4.18%+24.24%-30.68% 17.8B
+15.78%+0.07%-30.47%+110.64% 1.73B
-1.43%+7.25%-46.99%-80.83% 1.03B
-0.11%-2.16%-24.64%+21.56% 962M
+0.14%+0.30%+64.14%-5.44% 780M
+2.67%+1.05%-38.28%-44.75% 689M
+3.43%-8.53%-44.27%-48.79% 563M
-1.42%+0.69%-40.20%-37.25% 459M
-3.73%+3.32%+66.09%+45.53% 455M
Average +1.87%+4.01%+0.37%-15.90% 2.45B
Weighted average by Cap. +0.82%+6.76%+13.03%-19.57%

Financials

2024 2025
Net sales 501K 683K 585K 548K 946K 65.12M 955K 6.47M 2.52M 32.86M 2.56M 2.51M 109M 954K 1.3M 1.11M 1.04M 1.8M 124M 1.82M 12.32M 4.8M 62.56M 4.88M 4.78M 207M
Net income -7.08M -9.65M -8.27M -7.75M -13.35M -920M -13.48M -91.36M -35.57M -464M -36.22M -35.43M -1.54B -5.23M -7.13M -6.11M -5.73M -9.87M -680M -9.97M -67.55M -26.3M -343M -26.78M -26.2M -1.14B
Net Debt -5.17M -7.05M -6.04M -5.66M -9.76M -672M -9.85M -66.75M -25.98M -339M -26.46M -25.89M -1.12B -1.18M -1.61M -1.38M -1.29M -2.23M -154M -2.25M -15.26M -5.94M -77.52M -6.05M -5.92M -257M
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
26/08/26 GBX 1.350 +3.81% 850,445
25/08/26 GBX 1.300 -5.80% 3,125,127
24/08/26 GBX 1.380 +6.15% 12,404,644
21/08/26 GBX 1.300 -3.70% 5,229,933
20/08/26 GBX 1.350 +8.00% 5,533,595

Annual profits - Rate of surprise